title: [Carbohydrate antigen CA 19-9: value in pancreatic pathology].
abstract: In order to determine the diagnostic usefulness of the dosage of carbohydrate antigen (CA 19-9) serum levels in pancreatic diseases, 38 patients with pancreatic lesions proved at laparotomy were studied. Pancreatic lesions were classified into two groups: a) group I: pancreatic adenocarcinoma (17 cases) b) group II: benign pancreatic diseases (21 cases). CA 19-9 serum levels were statistically higher in patients of the first group (p less than 0.001). All patients except one with CA 19-9 higher than 60 U/ml had pancreatic carcinoma. All patients except two with CA 19-9 less than 60 U/ml had a benign lesion. The sensitivity and specificity of CA 19-9 were 88 and 95 p. 100 respectively. These results show that CA 19-9 dosage is useful in distinguishing between benign and malign lesions of the pancreas.
authors.forename: J
authors.initials: J
authors.lastname: Venot
authors.forename: D
authors.initials: D
authors.lastname: Vincent
authors.forename: A
authors.initials: A
authors.lastname: Gainant
authors.forename: B
authors.initials: B
authors.lastname: Descottes
authors.forename: F
authors.initials: F
authors.lastname: Cessot
authors.forename: C
authors.initials: C
authors.lastname: Beck
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D003937:Diagnosis, Differential; D005069:Evaluation Studies as Topic; D006801:Humans; D010182:Pancreatic Diseases / Q000175:diagnosis / Q000276:immunology*; D010190:Pancreatic Neoplasms / Q000276:immunology*; D011863:Radioimmunoassay; D012698:Serologic Tests
chemical_list: D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate
vernacular_title: L'antigène carbohydrate CA 19-9: intérêt au cours de la pathologie pancréatique.